Skip to content

Released Mar 31, 2014, before the open

10-K filed Mar 31, 2014, 90 days after period end · 0001193125-14-122624

Q4 2013 · 10-K
Revenue$105.89M−8.4% vs Q4 2012+15.3% vs Q3 2013
Net Income-$10.41MN/M vs Q4 2012N/M vs Q3 2013
EPS Diluted-$0.58N/M vs Q4 2012N/M vs Q3 2013
Gross Profit$71,763,000−19.2%
Operating Income-$10,079,000N/M
Operating Cash Flowderived$15,139,000N/M
Free Cash Flowderived$9,779,000N/M
Margins · derived
Gross margin67.8%−9.1 pt vs Q4 2012
Operating margin-9.5%−32.5 pt vs Q4 2012
Net margin-9.8%−29.7 pt vs Q4 2012

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2013Q4 2012Q4 2011Q4 2010
Revenue$105.89M$115.61M$118.64M$143.80M
Net Income-$10.41M$22.95M$7.89M$7.96M
EPS Diluted-$0.58$1.17$0.42$0.44

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR